Abstract:Gema Frühbeck, 1– 4 Victoria Catalán, 1– 3 Beatriz Ramírez, 1– 3 Víctor Valentí, 2, 3, 5 Sara Becerril, 1– 3 Amaia Rodríguez, 1– 3 Rafael Moncada, 2, 3, 6 Jorge Baixauli, 5 Camilo Silva, 2– 4 Javier Escalada, 2, 4 Javier Gómez-Ambrosi 1– 3 1 Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain; 2 Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain; 3 Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain; 4 Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, Spain; 5 Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain; 6 Department of Anesthesia, Clínica Universidad de Navarra, Pamplona, Spain Correspondence: Javier Gómez-Ambrosi, Metabolic Research Laboratory, Clínica Universidad de Navarra, Irunlarrea 1, Pamplona, 31008, Spain, Tel +34 948 425600 (ext. 806567), Email Background: Excess adiposity leads to a dysfunctional adipose tissue that contributes to the development of obesity-associated comorbidities such as type 2 diabetes (T2D). Interleukin-1 receptor antagonist (IL-1RA) is a naturally occurring antagonist of the IL-1 receptor with anti-inflammatory properties. The aim of the present study was to compare the circulating concentrations of IL-1RA and its mRNA expression in visceral adipose tissue (VAT) in subjects with normal weight (NW), obesity with normoglycemia (OB-NG), or obesity with impaired glucose tolerance or T2D (OB-IGT&T2D) and to analyze the effect of changes in body fat percentage (BF%) on IL-1RA levels. Methods: Serum concentrations of IL-1RA were measured in 156 volunteers. Expression of IL1RN mRNA in VAT obtained from 36 individuals was determined. In addition, the concentrations of IL-1RA were measured before and after weight gain as well as weight loss following a dietetic program or Roux-en-Y gastric bypass (RYGB). Results: Serum levels of IL-1RA were significantly increased in individuals with obesity, being further increased in the OB-IGT&T2D group (NW 440 ± 316, OB-NG 899 ± 562, OB-IGT&T2D 1265 ± 739 pg/mL; P < 0.001) and associated with markers of inflammation and fatty liver. IL1RN mRNA expression in VAT was significantly increased in the OB-IGT&T2D group and correlated in the global cohort with the mRNA expression of SPP1, CCL2, CD68 , and MMP9 . Levels of IL-1RA were not modified after modest changes in BF%, but RYGB-induced weight loss significantly decreased IL-1RA concentrations from 1233 ± 1009 to 660 ± 538 pg/mL ( P < 0.001). Conclusion: Serum IL-1RA concentrations are increased in patients with obesity being further elevated in obesity-associated IGT and T2D in association with markers of adipose tissue dysfunction. The mRNA expression of IL1RN is markedly increased in VAT of subjects with obesity and T2D in relation with genes involved in macrophage recruitment, inflammation and matrix remodeling. Serum IL-1RA concentrations are reduced when a notable amount of BF% is loss. Measurement of IL-1RA is an excellent biomarker of adipose tissue dysfunction in obesity-associated metabolic alterations. Keywords: IL-1RA, obesity, type 2 diabetes, inflammation, adipose tissue, adipokines The prevalence of obesity has increased alarmingly in the entire World threatening the increase in life expectancy achieved in the last decades. 1 Obesity favors the development of cardiometabolic alterations such as type 2 diabetes (T2D), dyslipidemia and non-alcoholic fatty liver disease (NAFLD), among other metabolic derangements, leading to an increase in morbidity and mortality in relation to excess adiposity. 2,3 The adipose tissue represents a highly dynamic and active endocrine organ as opposed to a passive depot for the accumulation of energy in the form of fat. 4,5 This multifunctional nature is based on the ability of adipocytes and other resident cells to secrete a wide variety of bioactive molecules, collectively termed as adipokines, which are involved in the regulation of many physiological processes such as appetite, inflammation, cardiovascular homeostasis as well as glucose and lipid metabolism. 4,6 Most adipocyte-derived factors have been proven to be dysregulated in pathophysiological alterations accompanied by changes in the amount of adipose tissue, thus providing evidence for their involvement in the development of obesity and associa -Abstract Truncated-

Increased expression of IL-1β in adipose tissue in obesity influences the development of colon cancer by promoting inflammation

Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls

Incremental Elevations in TNFα and IL6 in the Human Colon and Procancerous Changes in the Mucosal Transcriptome Accompany Adiposity

Peritumoral adipose tissue as a source of inflammatory and angiogenic factors in colorectal cancer

Obesity and colorectal cancer: molecular features of adipose tissue

Serum Levels of IL-1 RA Increase with Obesity and Type 2 Diabetes in Relation to Adipose Tissue Dysfunction and are Reduced After Bariatric Surgery in Parallel to Adiposity

NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development

Interleukin-16 is increased in obesity and alters adipogenesis and inflammation in vitro

Increased Interleukin-32 Levels in Obesity Promote Adipose Tissue Inflammation and Extracellular Matrix Remodeling: Effect of Weight Loss

IL-1β promotes adipogenesis by directly targeting adipocyte precursors

Interleukin-17A Gene Expression in Morbidly Obese Women

IL-1 Receptor Contributes to the Maintenance of the Intestinal Barrier via IL-22 during Obesity and Metabolic Syndrome in Experimental Model

Obesity Modulates Intestinal Intraepithelial T Cell Persistence, CD103 and CCR9 Expression, and Outcome in Dextran Sulfate Sodium-Induced Colitis

Increased Levels of Interleukin-36 in Obesity and Type 2 Diabetes Fuel Adipose Tissue Inflammation by Inducing Its Own Expression and Release by Adipocytes and Macrophages

Fas Signaling in Adipocytes Promotes Low-Grade Inflammation and Lung Metastasis of Colorectal Cancer Through Interaction with Bmx.

Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism

Targeting IL-23 for the interception of obesity-associated colorectal cancer

Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation

P029 Loss of adipose tissue protects mice from intestinal inflammation

High-fat Diet Aggravates Colitis Via Mesenteric Adipose Tissue Derived Exosome Metastasis-Associated Lung Adenocarcinoma Transcript 1

Significant neutrophil accumulation, IL-18 deposition, and active inflammasome in tumor regions of human pancreatic ductal adenocarcinoma.